A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors
Clinical trial NCT06779851 · TERMINATED
Trial details
- NCT number
- NCT06779851
- Sponsor
- Bright Peak Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2026-01-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.